Since its inception in 1920, The Union has had a focus on tuberculosis (TB) and innovating TB care.
We have now set out our 2022-2027 vision, objectives and strategy for ending TB. This can only be achieved collectively, with our members, partners and TB community – everyone has a role to play.
Together, we can bring an end to TB.
Our work in TB
The Union works towards the global elimination of TB. We support high-quality, accessible prevention and care for people with and at risk of TB, to expand the evidence base for TB care and prevention and implement new knowledge into policy and practice.
Project Axshya
In collaboration with local partners and over 15,000 community volunteers, The Union provided innovative tuberculosis (TB) interventions designed to serve traditionally hard-to-reach and at-risk populations in India.
Specific TB priority areas
Read more about how The Union is working to fight key areas of TB:
Child & Adolescent Tuberculosis
The Union works to develop, test, implement and scale up routine screening of child contacts of people with TB. We run observational studies and advocate to ensure children and adolescents are included in clinical trials that target diagnostics, vaccines and treatment of TB disease and infection.
TB-HIV, TB-Diabetes and other co-morbidities
The Union develops, tests, implements and scales up models of care for co-morbid conditions that increase the risk of developing TB, that are prevalent in high TB burden settings, or that adversely affect TB treatment outcomes.
The Zoonotic TB Sub-section was instrumental in the creation of the first-ever Roadmap for Zoonotic TB, a policy document that addressed the major health and economic impacts of the disease, created in collaboration with the World Health Organization.
Members work together to influence global policy and practice, ensuring their work has a greater global impact.
Understand the issues with our factsheets
Tuberculosis Union news
Timor-Leste mayors unite for stronger action on tobacco control, NCDs prevention and ending TB
The first ever Timor-Leste Mayors Summit for Health and Development successfully concluded in Dili with the unanimous adoption of a…
Experts identify clinical standards for adverse effects to TB treatment
A panel of 65 global experts have identified eight clinical standards for the management of adverse effects during treatment for tuberculosis (TB).
Assessing TB-related comorbidities, risks and disability in China
A new study in China has found that it was possible and valuable to assess people with tuberculosis (TB) for symptoms, comorbidities, risk factors and disability at the start and end of TB treatment.
Risk of TB nine times higher in prisons globally
For the first time ever researchers, sponsored by The Union, have estimated the rate of tuberculosis (TB) in incarcerated persons, having analysed data from almost every country in the world (193 out of 195 countries) between 2000 and 2019.
International Nurses Day 2023: Fernando Augusto Dias e Sanches
Where do you work as a nurse?
I currently work at the Tuberculosis Research Center at Thorax Diseases Instituto,…
Nepal's Prime Minister commits to end TB and tobacco
In March, Dr Tara Singh Bam, Director of The Union Asia Pacific met with the Prime Minister of Nepal to discuss strategies to prevent non-communicable diseases, tuberculosis (TB) and tobacco use.
Until recently, the focus has been on finding and treating people with TB. But now bold targets for TB prevention have been outlined in the recent UN High-Level Meeting on TB. The Union develops, tests, implements and scales up models of care to increase the uptake and completion of TB preventive treatments in key high risk groups including children under 5 and people living with HIV.
'Prevent Tuberculosis: Management of TB Infection' is a free course which improves knowledge of all aspects of the management of TB infection including the diagnosis and treatment of tuberculosis with the specific aim of increasing country-level implementation of TB prevention among i) household contact of people affected by TB, especially those under five years of age, ii) persons with risk factors to develop TB, and iii) people living with HIV in care.